Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Clever Leaves Holdings Inc. (CLVR)

    Price:

    0.00 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    CLVR
    Name
    Clever Leaves Holdings Inc.
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Price
    0.000
    Market Cap
    702.000
    Enterprise value
    -1.468M
    Currency
    USD
    Ceo
    Andres Fajardo
    Full Time Employees
    296
    Ipo Date
    2020-12-18
    City
    Boca Raton
    Address
    6501 Congress Avenue

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Shionogi & Co., Ltd.

    VALUE SCORE:

    6

    Symbol
    SGIOF
    Market Cap
    3.443T
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    2nd position

    Hikma Pharmaceuticals PLC

    VALUE SCORE:

    12

    Symbol
    HKMPY
    Market Cap
    4.081B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    The best

    Hikma Pharmaceuticals PLC

    VALUE SCORE:

    12

    Symbol
    HKMPF
    Market Cap
    4.201B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.000
    P/S
    0.000
    P/B
    0.000
    Debt/Equity
    0.086
    EV/FCF
    0.411
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -0.272
    Earnings yield
    -28.545k
    Debt/assets
    0.067
    FUNDAMENTALS
    Net debt/ebidta
    0.282
    Interest coverage
    -339.000
    Research And Developement To Revenue
    0.065
    Intangile to total assets
    0.085
    Capex to operating cash flow
    -0.003
    Capex to revenue
    0.002
    Capex to depreciation
    0.011
    Return on tangible assets
    -0.626
    Debt to market cap
    2.973k
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -0.000
    P/CF
    -0.000
    P/FCF
    -0.000
    RoA %
    -57.290
    RoIC %
    -59.257
    Gross Profit Margin %
    37.641
    Quick Ratio
    1.627
    Current Ratio
    2.399
    Net Profit Margin %
    -102.767
    Net-Net
    2.300
    FUNDAMENTALS PER SHARE
    FCF per share
    -7.361
    Revenue per share
    11.111
    Net income per share
    -11.418
    Operating cash flow per share
    -7.341
    Free cash flow per share
    -7.361
    Cash per share
    4.358
    Book value per share
    15.448
    Tangible book value per share
    13.756
    Shareholders equity per share
    15.448
    Interest debt per share
    1.361
    TECHNICAL
    52 weeks high
    0.500
    52 weeks low
    0.000
    Current trading session High
    0.000
    Current trading session Low
    0.000
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    CN
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    DESCRIPTION

    Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.

    NEWS
    https://images.financialmodelingprep.com/news/comparing-clever-leaves-nasdaqclvr-and-palatin-technologies-pinkptnt-20251226.jpg
    Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT)

    defenseworld.net

    2025-12-26 02:18:57

    Palatin Technologies (PINK: PTNT - Get Free Report) and Clever Leaves (NASDAQ: CLVR - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings. Profitability This table compares Palatin Technologies and

    https://images.financialmodelingprep.com/news/clever-leaves-announces-voluntary-delisting-and-sec-deregistration-20240426.jpg
    Clever Leaves Announces Voluntary Delisting and SEC Deregistration

    globenewswire.com

    2024-04-26 16:10:00

    TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasdaq Stock Market LLC (“Nasdaq”) and deregister its Securities in order to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”).

    https://images.financialmodelingprep.com/news/clever-leaves-reports-fourth-quarter-and-full-year-2023-20240401.jpg
    Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

    globenewswire.com

    2024-04-01 16:01:00

    - 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information is provided in US dollars unless otherwise indicated.

    https://images.financialmodelingprep.com/news/high-growth-top-pot-stocks-making-moves-into-march-20240303.jpg
    High Growth: Top Pot Stocks Making Moves into March 2024

    marijuanastocks.com

    2024-03-03 12:00:10

    As the cannabis industry continues to flourish in the United States, investors are keenly watching the market for top-performing marijuana stocks. With the industry projected to reach a staggering $30 billion by 2025, the allure of double-digit gains before March is strong. Recent updates on federal legalization efforts have further invigorated the market. These developments promise to expand the industry's legal framework, potentially unlocking vast untapped markets. Investors are advised to employ technical analysis and proper risk management strategies. These tools are crucial for navigating the volatile cannabis sector. They help identify promising entry and exit points, maximizing returns while minimizing risks.

    https://images.financialmodelingprep.com/news/clever-leaves-and-paradise-seeds-to-develop-and-register-20240213.jpg
    Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia

    globenewswire.com

    2024-02-13 08:30:00

    TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for cultivation across Colombia and Latin America. The two companies have already begun rigorous selection, phenotyping, and agronomic trials of several Paradise varieties at Clever Leaves' facility in order to register market-leading cultivars for production and commercialization.

    https://images.financialmodelingprep.com/news/clever-leaves-granted-australian-gmp-certification-for-cannabis-products-20240103.jpg
    Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)

    globenewswire.com

    2024-01-03 08:30:00

    Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products.

    https://images.financialmodelingprep.com/news/clever-leaves-holdings-inc-investor-reminder-robbins-llp-is-investigating-20231207.jpg
    Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors

    businesswire.com

    2023-12-07 14:50:00

    SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors.

    https://images.financialmodelingprep.com/news/robbins-llp-reminds-investors-it-is-investigating-clever-leaves-20231201.jpg
    Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder

    businesswire.com

    2023-12-01 14:46:00

    SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder.

    https://images.financialmodelingprep.com/news/calling-all-clever-leaves-holdings-inc-clvr-investors-contact-20231130.jpg
    Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

    businesswire.com

    2023-11-30 11:51:00

    NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which merged with Clever Leaves Holdings Inc. (“Clever Leaves”) (NASDAQ: CLVR) on December 17, 2020. Investors who purchased Schultze are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/clvr. Inv.

    https://images.financialmodelingprep.com/news/calling-all-clever-leaves-holdings-inc-clvr-investors-contact-20231129.jpg
    Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

    businesswire.com

    2023-11-29 13:12:00

    NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which merged with Clever Leaves Holdings Inc. (“Clever Leaves”) (NASDAQ: CLVR) on December 17, 2020. Investors who purchased Schultze are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/clvr. In.

    https://images.financialmodelingprep.com/news/clever-leaves-holdings-inc-clvr-q3-2023-earnings-call-20231110.jpg
    Clever Leaves Holdings, Inc. (CLVR) Q3 2023 Earnings Call Transcript

    seekingalpha.com

    2023-11-10 03:36:01

    Clever Leaves Holdings, Inc. (NASDAQ:CLVR ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Jackie Keshner - Director of Investor Relations Andres Fajardo - Chief Executive Officer Hank Hague - Chief Financial Officer Conference Call Participants Bobby Burleson - Canaccord Genuity Operator Good day, and welcome Clever Leaves Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.

    https://images.financialmodelingprep.com/news/clever-leaves-reports-third-quarter-2023-results-20231109.jpg
    Clever Leaves Reports Third Quarter 2023 Results

    globenewswire.com

    2023-11-09 16:01:00

    - Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue -

    https://images.financialmodelingprep.com/news/clever-leaves-to-hold-third-quarter-2023-conference-call-20231102.jpg
    Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET

    globenewswire.com

    2023-11-02 08:30:00

    TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference call on Thursday, November 9, 2023 at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2023. The Company will provide its financial results in a press release prior to the conference call.

    https://images.financialmodelingprep.com/news/clever-leaves-regains-compliance-with-nasdaq-minimum-bid-price-20230913.jpg
    Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement

    globenewswire.com

    2023-09-13 08:30:00

    TOCANCIPÁ, Colombia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on September 11, 2023 informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on the Nasdaq Capital Market.

    https://images.financialmodelingprep.com/news/clever-leaves-cannabis-operations-declared-carbon-neutral-a-first-20230829.jpg
    Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company

    globenewswire.com

    2023-08-29 09:00:00

    The CO2 Neutrality Certification Reflects Clever Leaves' Commitment to Environmental Sustainability and long-term vision for the cannabis industry.

    https://images.financialmodelingprep.com/news/clever-leaves-announces-1for30-reverse-stock-split-to-aid-compliance-20230824.jpg
    Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements

    globenewswire.com

    2023-08-24 08:00:00

    TOCANCIPÁ, Colombia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Board of Directors has approved a 1-for-30 reverse split of its common shares (the “Reverse Share Split”). The Reverse Share Split will take effect at approximately 5:00 p.m. Eastern Time on August 24, 2023.